These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 25134891)

  • 21. Effect of annual mass administration of diethylcarbamazine and albendazole on bancroftian filariasis in five villages in south India.
    Ramaiah KD; Vanamail P; Yuvaraj J; Das PK
    Trans R Soc Trop Med Hyg; 2011 Aug; 105(8):431-7. PubMed ID: 21601901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India.
    Rajendran R; Sunish IP; Mani TR; Munirathinam A; Arunachalam N; Satyanarayana K; Dash AP
    Trop Med Int Health; 2006 Jun; 11(6):851-61. PubMed ID: 16772007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature.
    Wynd S; Melrose WD; Durrheim DN; Carron J; Gyapong M
    Bull World Health Organ; 2007 Jun; 85(6):493-8. PubMed ID: 17639248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of parasite drug resistance in human lymphatic filariasis.
    Cobo F
    Rev Esp Quimioter; 2016 Dec; 29(6):288-295. PubMed ID: 27858056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis.
    Krentel A; Fischer PU; Weil GJ
    PLoS Negl Trop Dis; 2013 Nov; 7(11):e2447. PubMed ID: 24278486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors Associated with the Acceptability of Mass Drug Administration for Filariasis: A Systematic Review.
    Abdul Halim AFN; Ahmad D; Miaw Yn JL; Masdor NA; Ramly N; Othman R; Kandayah T; Hassan MR; Dapari R
    Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36232271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EBM verdict: should albendazole be used for treating lymphatic filariasis? No.
    Onakpoya IJ
    BMJ Evid Based Med; 2019 Aug; 24(4):141-142. PubMed ID: 30971416
    [No Abstract]   [Full Text] [Related]  

  • 28. Measuring impact on filarial infection status in a community study: role of coverage of mass drug administration (MDA).
    Kumar A; Sachan P
    Trop Biomed; 2014 Jun; 31(2):225-9. PubMed ID: 25134891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphatic filariasis and Brugia timori: prospects for elimination.
    Fischer P; Supali T; Maizels RM
    Trends Parasitol; 2004 Aug; 20(8):351-5. PubMed ID: 15246315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame.
    Rebollo MP; Bockarie MJ
    Expert Rev Anti Infect Ther; 2013 Jul; 11(7):723-31. PubMed ID: 23879610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphatic filariasis: constraints ahead.
    Mishra CP; Singh N
    Indian J Public Health; 2003; 47(1):27-30. PubMed ID: 14723292
    [No Abstract]   [Full Text] [Related]  

  • 32. Towards elimination of lymphatic filariasis in India.
    Das PK; Ramaiah KD; Augustin DJ; Kumar A
    Trends Parasitol; 2001 Oct; 17(10):457-60. PubMed ID: 11587940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Albendazole for the control and elimination of lymphatic filariasis: systematic review.
    Critchley J; Addiss D; Ejere H; Gamble C; Garner P; Gelband H;
    Trop Med Int Health; 2005 Sep; 10(9):818-25. PubMed ID: 16135187
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.